Park Joo-Hyun, Hong Jung Yong, Han Kyungdo, Shen Jay J
Department of Family Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan 15355, Republic of Korea.
Department of Healthcare Administration and Policy, School of Public Health, University of Nevada Las Vegas, Las Vegas, NV 89154, USA .
Cancers (Basel). 2025 Jul 7;17(13):2262. doi: 10.3390/cancers17132262.
: Sex differences in the effects of hyperglycemia and smoking on bladder cancer risk remain poorly understood, despite their known roles as modifiable risk factors. We investigated the sex-specific associations of prediabetes, diabetes, and smoking with bladder cancer risk. : We analyzed data from 9,492,331 cancer-free adults (54.8% men) who underwent the 2009 Korean national health screening. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for bladder cancer incidence were calculated using Cox proportional hazards models. : Over a median follow-up of 8.3 years, 12,095 men and 2467 women were diagnosed with bladder cancer. The male-to-female incidence ratio was 4.1:1 among never-smokers with normoglycemia and 2.7:1 among ever-smokers with diabetes. In women, both prediabetes and diabetes were associated with elevated bladder cancer risk (aHRs, 95% CIs: 1.12, 1.02-1.24; and 1.27, 1.13-1.43). In men, only diabetes showed an increased risk (aHR: 1.22, 1.12-1.32). Combined diabetes and smoking increased the risk synergistically in women (aHR: 2.75, 1.95-3.87; synergy index = 2.38, < 0.01), while the effect was additive in men (aHR: 1.82, 1.70-1.95). : The typical male predominance in bladder cancer incidence appeared attenuated in the presence of hyperglycemia and smoking, suggesting that these risk factors may have a relatively greater impact on bladder cancer risk among women. These findings underscore the importance of targeted bladder cancer prevention strategies, with particular attention to women with hyperglycemia who smoke, given their disproportionately elevated risk.
尽管高血糖和吸烟作为可改变的风险因素在膀胱癌风险中的作用已为人所知,但它们对膀胱癌风险影响的性别差异仍知之甚少。我们研究了糖尿病前期、糖尿病和吸烟与膀胱癌风险的性别特异性关联。
我们分析了9492331名无癌症成年人(54.8%为男性)的数据,这些人参加了2009年韩国国民健康筛查。使用Cox比例风险模型计算膀胱癌发病率的调整后风险比(aHRs)和95%置信区间(CIs)。
在中位随访8.3年期间,12095名男性和2467名女性被诊断为膀胱癌。在血糖正常的从不吸烟者中,男性与女性的发病率之比为4.1:1;在患有糖尿病的曾经吸烟者中,这一比例为2.7:1。在女性中,糖尿病前期和糖尿病均与膀胱癌风险升高相关(aHRs,95% CIs:1.12,1.02 - 1.24;以及1.27,1.13 - 1.43)。在男性中,只有糖尿病显示出风险增加(aHR:1.22,1.12 - 1.32)。糖尿病与吸烟共同作用在女性中协同增加风险(aHR:2.75,1.95 - 3.87;协同指数 = 2.38,<0.01),而在男性中作用是相加的(aHR:1.82,1.70 - 1.95)。
在存在高血糖和吸烟的情况下,膀胱癌发病率中典型的男性优势似乎减弱,这表明这些风险因素可能对女性的膀胱癌风险影响相对更大。这些发现强调了针对性膀胱癌预防策略的重要性,鉴于血糖高且吸烟的女性风险不成比例地升高,应特别关注她们。